175 related articles for article (PubMed ID: 20368356)
1. The Ras effector RASSF2 controls the PAR-4 tumor suppressor.
Donninger H; Hesson L; Vos M; Beebe K; Gordon L; Sidransky D; Liu JW; Schlegel T; Payne S; Hartmann A; Latif F; Clark GJ
Mol Cell Biol; 2010 Jun; 30(11):2608-20. PubMed ID: 20368356
[TBL] [Abstract][Full Text] [Related]
2. Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2.
Kumari G; Mahalingam S
Exp Cell Res; 2009 Oct; 315(16):2775-90. PubMed ID: 19555684
[TBL] [Abstract][Full Text] [Related]
3. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.
Akino K; Toyota M; Suzuki H; Mita H; Sasaki Y; Ohe-Toyota M; Issa JP; Hinoda Y; Imai K; Tokino T
Gastroenterology; 2005 Jul; 129(1):156-69. PubMed ID: 16012945
[TBL] [Abstract][Full Text] [Related]
4. [Methylation and protein expression of RASSF2 in prostate cancer].
Liu G; Yin B; Song YS
Zhonghua Nan Ke Xue; 2013 Feb; 19(2):107-10. PubMed ID: 23441448
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
[TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences.
Schagdarsurengin U; Richter AM; Hornung J; Lange C; Steinmann K; Dammann RH
Mol Cancer; 2010 Sep; 9():264. PubMed ID: 20920251
[TBL] [Abstract][Full Text] [Related]
7. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor.
Vos MD; Ellis CA; Elam C; Ulku AS; Taylor BJ; Clark GJ
J Biol Chem; 2003 Jul; 278(30):28045-51. PubMed ID: 12732644
[TBL] [Abstract][Full Text] [Related]
8. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.
Eckfeld K; Hesson L; Vos MD; Bieche I; Latif F; Clark GJ
Cancer Res; 2004 Dec; 64(23):8688-93. PubMed ID: 15574778
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.
Imai T; Toyota M; Suzuki H; Akino K; Ogi K; Sogabe Y; Kashima L; Maruyama R; Nojima M; Mita H; Sasaki Y; Itoh F; Imai K; Shinomura Y; Hiratsuka H; Tokino T
Cancer Sci; 2008 May; 99(5):958-66. PubMed ID: 18294275
[TBL] [Abstract][Full Text] [Related]
10. Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to Chemotherapy.
Clark J; Freeman J; Donninger H
Mol Biol Int; 2012; 2012():705948. PubMed ID: 22693671
[TBL] [Abstract][Full Text] [Related]
11. The RASSF1A tumor suppressor activates Bax via MOAP-1.
Vos MD; Dallol A; Eckfeld K; Allen NP; Donninger H; Hesson LB; Calvisi D; Latif F; Clark GJ
J Biol Chem; 2006 Feb; 281(8):4557-63. PubMed ID: 16344548
[TBL] [Abstract][Full Text] [Related]
12. Proteomics Analysis Reveals Novel RASSF2 Interaction Partners.
Barnoud T; Wilkey DW; Merchant ML; Clark JA; Donninger H
Cancers (Basel); 2016 Mar; 8(3):. PubMed ID: 26999212
[TBL] [Abstract][Full Text] [Related]
13. Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals.
Kumari G; Singhal PK; Rao MR; Mahalingam S
J Mol Biol; 2007 Apr; 367(5):1294-311. PubMed ID: 17320110
[TBL] [Abstract][Full Text] [Related]
14. Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity.
Song H; Oh S; Oh HJ; Lim DS
Biochem Biophys Res Commun; 2010 Jan; 391(1):969-73. PubMed ID: 19962960
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
[TBL] [Abstract][Full Text] [Related]
16. RASSF2 associates with and stabilizes the proapoptotic kinase MST2.
Cooper WN; Hesson LB; Matallanas D; Dallol A; von Kriegsheim A; Ward R; Kolch W; Latif F
Oncogene; 2009 Aug; 28(33):2988-98. PubMed ID: 19525978
[TBL] [Abstract][Full Text] [Related]
17. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P
BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876
[TBL] [Abstract][Full Text] [Related]
19. The RASSF1A tumor suppressor.
Donninger H; Vos MD; Clark GJ
J Cell Sci; 2007 Sep; 120(Pt 18):3163-72. PubMed ID: 17878233
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment.
Shen Z; Qin X; Yan M; Li R; Chen G; Zhang J; Chen W
Oncotarget; 2017 Jan; 8(1):1290-1303. PubMed ID: 27901488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
